Tyndall Capital Partners L P, 10% Owner at Onconova Therapeutics, Inc. (ONTX), sold 10,927 shares at $2.81 ($31K) on 2019-07-10, disclosed to the SEC on 2019-07-11.
Open-market sale of $31k ONTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.84 | 8,185 | $23K | 75.1% |
| 2 | $2.81 | 2,742 | $8K | 24.9% |
| Total | $2.83 avg | 10,927 | $31K | 100% |
| Filing → |
| ONTX | SELL | 2019-09-20 | $210K | — | Filing → |
| ONTX | SELL | 2019-09-13 | $3K | — | Filing → |
| ONTX | SELL | 2019-09-11 | $1K | — | Filing → |